WHANIN PHARM CO.,LTD Logo

WHANIN PHARM CO.,LTD

Develops and sells pharmaceuticals, specializing in CNS, cardiovascular, and GI drugs.

016580 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 송파구 법원로6길 11 (문정동, 환인빌딩), 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Whanin Pharm Co., Ltd. is a pharmaceutical company focused on the development, manufacturing, and sale of therapeutic products. The company specializes in medications for the Central Nervous System (CNS), offering a range of neuropsychiatric drugs including anti-depressants, anti-psychotics, and nootropics. In addition to its core CNS portfolio, Whanin Pharm also produces pharmaceuticals for other therapeutic categories such as cardiovascular and gastrointestinal treatments, as well as antibiotics. The company actively engages in research and development to create innovative medications, extending its focus beyond CNS to the broader healthcare sphere.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for WHANIN PHARM CO.,LTD and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.7 MB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-01 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.9 KB
2025-07-11 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 19.7 KB
2025-07-07 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 30.6 KB

Automate Your Workflow. Get a real-time feed of all WHANIN PHARM CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for WHANIN PHARM CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
STELLA PHARMA CORPORATION Logo
Develops boron drugs for Boron Neutron Capture Therapy (BNCT), a targeted cancer radiation treatment.
Japan 4888
StemRIM Inc. Logo
Developing regenerative medicines that use the body's own stem cells to treat intractable diseases.
Japan 4599
STENOCARE A/S Logo
Develops and distributes prescription medical cannabis oils in Northern Europe and Australia.
Denmark STENO
ST PHARM CO., LTD. Logo
A global CDMO specializing in APIs and RNA therapeutics for the gene therapy market.
South Korea 237690
Sugentech, Inc. Logo
Develops advanced in-vitro diagnostic systems for hospitals, clinics, and at-home use.
South Korea 253840
SUHEUNG CO.,LTD. Logo
Global manufacturer of capsules and contract manufacturing for pharma/nutraceutical industries.
South Korea 008490
Sumitomo Pharma Co., Ltd. Logo
R&D pharma creating medicines for oncology, psychiatry & neurology, focusing on Japan & the US.
Japan 4506
SunBio, Inc. Logo
Develops biopharmaceuticals and devices like artificial blood using proprietary PEGylation technology.
South Korea 067370
Swedish Orphan Biovitrum Logo
Develops innovative therapies for rare diseases in haematology, immunology, and specialty care.
Sweden SOBI
SymBio Pharmaceuticals Limited Logo
Acquires and commercializes specialty drugs for unmet needs in Japan and the Asia-Pacific region.
Japan 4582

Talk to a Data Expert

Have a question? We'll get back to you promptly.